Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2020.02.09.940460

Lower intake of animal-based products links to improved weight status, independent of depressive symptoms and personality in the general population

Medawar, E.·Enzenbach, C.·Roehr, S.·Villringer, A.·Riedel-Heller, S.·Witte, A. V.
View original source ↗Export metadata ↓

Abstract

BackgroundRestricting animal-based products from diet may exert beneficial effects on weight status, however whether this is also true for emotional health is unclear. Moreover, differential personality traits may underlie restrictive eating habits and therefore potentially confound diet-health associations. To systematically assess whether restrictive dietary intake of animal-based products relates to lower weight and higher depressive symptoms, and how this is linked to personality traits in the general population. MethodsCross-sectional data was taken from the baseline LIFE-Adult study collected from 2011-2014 in Leipzig, Germany (n = 8943). Main outcomes of interest were 12-month dietary frequency of animal-derived products measured using a Food Frequency Questionnaire (FFQ), body mass index (BMI) (kg/m2), and the Center of Epidemiological Studies Depression Scale (CES-D). Personality traits were assessed in a subsample of n = 7906 using the Five Factor Inventory (NEO-FFI). FindingsHigher restriction of animal-based product intake was associated with a lower BMI (age-, sex- and education-adjusted, n = 8943; {beta} = -.07, p < .001), but not depression score. Personality, i.e. lower extraversion (F (1,7897) = 9.8, p = .002), was related to frequency of animal product intake. Further, not diet but personality was significantly associated with depression, i.e. higher neuroticism ({beta} = .024), lower extraversion ({beta} = -.006), lower agreeableness ({beta} = -.001), lower conscientiousness ({beta} = -.007) and higher BMI ({beta} = .004) (all p < .001, overall model, R2 = .21). The beneficial association with lower weight seemed to be driven by the frequency of meat product intake and not secondary animal products. Likewise, the overall number of excluded food items from the individual diet was associated with a lower BMI (age-, sex- and education-adjusted, n = 8938, {beta} = -.15, p < .001) and additionally with lower depression scores ({beta} = -.004, t = -4.1, p < .001, R2 = .05, corrected for age, sex and education), also when additionally correcting for differences in personality traits ({beta} = -.003, t = -2.7, p = .007, R2 = .21). InterpretationHigher restriction of animal-based products in the diet was significantly associated with a lower BMI, but not with depressive symptoms scores in a large well-characterized population-based sample of adults. In addition, we found that certain personality traits related to restricting animal-based products - and that those traits, but not dietary habits, explained a considerable amount of variance in depressive symptoms. Upcoming longitudinal studies need to confirm these findings and to test the hypothesis if restricting animal-based products, esp. primary animal products ((processed) meat, wurst), conveys benefits on weights status, hinting to a beneficial relationship of animal-based restricted diets in regard to prevention and treatment of overweight and obesity. FundingWe thank all study participants. We very much appreciate the help of the physicians who performed the clinical examinations and data collection, in particular Ulrike Scharrer, Annett Wiedemann, Kerstin Wirkner and her team. This work was supported by LIFE--Leipzig Research Centre for Civilisation Diseases, University of Leipzig. LIFE is funded by means of the European Union, by means of the European Social Fund (ESF), by the European Regional Development Fund (ERDF), and by means of the Free State of Saxony within the framework of the excellence initiative. This work was supported by a scholarship (EM) by the German Federal Environmental Foundation and by the grants of the German Research Foundation contract grant number CRC 1052 "Obesity mechanisms" Project A1 (AV) and WI 3342/3-1 (AVW). The corresponding author had full access to all the data in the included in the analysis and had final responsibility for the decision to submit for publication. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=146 HEIGHT=200 SRC="FIGDIR/small/940460v1_ufig1.gif" ALT="Figure 1"> View larger version (23K): org.highwire.dtl.DTLVardef@1f81d8org.highwire.dtl.DTLVardef@85bd35org.highwire.dtl.DTLVardef@48fd83org.highwire.dtl.DTLVardef@1fbc053_HPS_FORMAT_FIGEXP M_FIG C_FIG

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Medawar, E., Enzenbach, C., Roehr, S., Villringer, A., Riedel-Heller, S., Witte, A. V.. 2020-02-10. Lower intake of animal-based products links to improved weight status, independent of depressive symptoms and personality in the general population. https://doi.org/10.1101/2020.02.09.940460

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗